If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccesso Technology Group Regulatory News (ACSO)

Share Price Information for Accesso Technology Group (ACSO)

Share Price is delayed by 15 minutes
Get Live Data
320.50    -2.50 (-0.77%)
Bid:
322.50
Ask:
326.50
Spread: 4.00 (1.24%)
Market Cap: £103.82m
ACSO Live PriceLast checked at - London Stock Exchange

Intraday Accesso Technology Group Share Chart

Update on the formal sale process

15 Oct 2019 07:00

RNS Number : 8424P
Accesso Technology Group PLC
15 October 2019
 

15 October 2019

 

ACCESSO TECHNOLOGY GROUP PLC 

 

("accesso" or the "Company")

 

Update on the formal sale process

 

accesso Technology Group plc (AIM: ASCO), the premier technology solutions provider to leisure, entertainment, hospitality, attractions and cultural markets, provides the following update on its announced formal sale process (the "Formal Sale Process") under the City Code on Takeovers and Mergers (the "Code").

 

Following the receipt of a number of unsolicited approaches and in consultation with the UK Takeover Panel, the Company announced the commencement of a Formal Sale Process on 24 July 2019. In reaching its decision, the Board considered that a Formal Sale Process was the most appropriate process to ascertain whether such interest could translate into an offer for the Company on terms which the Board would be prepared to recommend to accesso shareholders.

 

As part of the Formal Sale Process, the Company and its advisers have interacted with a number of interested parties. After initial discussions, many of the parties submitted written non-binding indications of interest that the Company regarded as acceptable to warrant allowing those parties to engage with management on the Company's business, operational and financial performance. Following meetings with management, the interested parties were asked to submit refreshed indications of interest by the end of September 2019. The Company and its advisers have now received refreshed indications of interest from a number of the interested parties, none of which are at a level that the Board feels offers sufficient value to shareholders. The Board and its advisers are continuing to engage in discussions with certain of these parties to determine whether an offer for the Company can be delivered at a value that the Board considers is attractive to shareholders.

 

Whilst the Formal Sale Process remains ongoing, the Board and the Company's management team continues to execute on its current strategic plan to realign and better integrate the Company's product and service offerings and to maximise the penetration of the estimated $3.4 billion(1) total addressable market (TAM) opportunity. Execution of the plan is in response to the market shift towards integrated guest experiences, enabling accesso to leverage its unique product suite to improve business outcomes for customers. If the Formal Sale Process does not result in an acceptable offer being made to accesso shareholders, the Board and the Company's management team are fully prepared to continue to execute this plan.

 

This announcement is not a firm intention to make an offer under Rule 2.7 of the Code and there can be no certainty that any offers will be made as a result of the Formal Sale Process, that any sale or other transaction will be concluded, nor as to the terms on which any offer or other transaction may be made.

 

The Board reserves the right to alter any aspect of the Formal Sale Process or to terminate it at any time and will make further announcements when appropriate. The Board reserves the right to reject any approach or terminate discussions with any interested party or participant at any time.

 

(1) Internal management analysis.

 

 

For further information please contact:

accesso Technology Group plc

Paul Noland, Chief Executive Officer

John Alder, Chief Financial Officer

Simon Chisholm, Investor Relations

 

 

+44 (0)118 934 7400

 

 

+44 (0)1825 723 440

KeyBanc Capital Markets Inc. (Lead Financial Adviser)

Thomas Mazzucco, Chris Headrick

 

 

 

US: +1 415 659 0934

US: +1 415 486 3410

 

Canaccord Genuity Limited (Rule 3 Adviser, Nominated Adviser and Joint Broker)

Simon Bridges, Richard Andrews

 

+44 (0)20 7523 8000

 

 

 

 

Numis Securities Limited (Financial Adviser and Joint Broker)

Simon Willis, Mark Lander

 

+44 (0)20 7260 1000

 

 

 

FTI Consulting, LLP

Matt Dixon, Chris Birt

 

+44 (0)20 3727 1000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUSRWRKWARAAA
Date   Source Headline
30th Jun 20267:00 amRNSDirector/PDMR Shareholding
25th Jun 202611:32 amRNSDirector/PDMR Shareholding
5th Jun 20267:00 amRNSHolding(s) in Company
28th May 20266:00 pmRNSHolding(s) in Company
28th May 20267:00 amRNSResult of AGM
18th May 20267:00 amRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSChief Executive Officer Succession
29th Apr 20267:00 amRNSAnnual Report and Notice of AGM
22nd Apr 20267:00 amRNSAppointment of Non-Executive Director
1st Apr 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSAcquisition of Dexibit
30th Mar 20267:00 amRNSFinal Results
20th Mar 20266:05 pmRNSHolding(s) in Company
18th Mar 20264:54 pmRNSCompletion of Tender Offer & Total Voting Rights
13th Mar 20261:34 pmRNSResult of Tender Offer
13th Mar 20261:28 pmRNSResult of General Meeting
11th Feb 20267:00 amRNSTender Offer
10th Feb 20267:00 amRNS-RExpansion of Strategic Partnership with Adyen
6th Feb 20263:06 pmRNSDirector/PDMR Shareholding
2nd Feb 20267:00 amRNSTotal Voting Rights
29th Jan 20267:00 amRNSTrading Update and Tender Offer
9th Jan 20265:30 pmRNSHolding(s) in Company
8th Jan 20267:00 amRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTrading Update
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20256:02 pmRNSHolding(s) in Company
22nd Dec 20256:02 pmRNSHolding(s) in Company
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 202511:33 amRNSHolding(s) in Company
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.